RadNet, Inc.

RadNet, Inc. Earnings Recaps

RDNT Health Care 3 recaps
Q1 2026 May 12, 2026

RadNet's stock declined 3.9% post-earnings as investors responded to surprisingly cautious outlook commentary and deceleration signals within the Digital Health segment, despite reported revenue and EBITDA gains. The market appears concerned that margin expansion and growth momentum may not sustain at the current pace.

Key takeaways
  • Revenue and adjusted EBITDA both set first quarter records, up 22.1% and 36.3% year-over-year, respectively, though results were impacted negatively by $13 million in revenue and $9 million in EBITDA from severe weather in Jan-Feb.
  • Adjusted EBITDA margin improved by 115 basis points year-over-year, or 52 basis points on a weather-adjusted basis, driven by a shift toward higher-margin advanced imaging protocols now representing 29.3% of procedural volume.
  • PET/CT procedures increased 35.2% aggregate and 14.7% same-center, primarily fueled by clinical demand in prostate cancer staging and neurological applications.
  • RadNet completed multiple acquisitions including Radiology Regional (13 centers) and Northwest Radiology (6 centers), with ongoing integration efforts focusing on AI-powered operational enhancements.
  • Despite strong operational commentary, cautious future guidance and possible Digital Health segment deceleration weighed on sentiment, reflecting concern about sustaining margin and growth trajectory amid integration and investment costs.
Full recap
Q3 2025 Nov 10, 2025

RadNet delivered outstanding third-quarter results, with record revenues and adjusted EBITDA outperforming internal forecasts, driven by robust demand for advanced imaging and improved reimbursement rates.

Key takeaways
  • Total revenue rose 13.4% and adjusted EBITDA increased 15.2% year-over-year, achieving a 26 basis point margin improvement.
  • Advanced imaging procedures grew by 13% overall, with a shift towards higher-margin services contributing to enhanced profitability.
  • Successful implementation of AI technology and strategic acquisitions, like iCAD, are significantly expanding service capabilities and operational efficiencies.
  • Enhanced reimbursement rates from capitated and commercial payers underline RadNet's value proposition as a cost-effective alternative to hospital imaging.
  • Full-year 2025 guidance for revenue and adjusted EBITDA has been increased due to strong performance and positive trends continuing into Q4.
Full recap
Q2 2025 Aug 11, 2025

RadNet, Inc. posted record revenue and adjusted EBITDA in Q2 2025, rebounding from previous disruptions, driven by advanced imaging growth and improved reimbursement rates.

Key takeaways
  • Q2 total revenue reached a record $498.2 million, up 8.4% year-over-year, with Digital Health segment revenue surging 30.9%.
  • Adjusted EBITDA increased 12.3% to a record $81.2 million, reflecting improved operational efficiency and margin expansion.
  • Advanced imaging procedures comprised 27.5% of total procedures, spurred by investments in technology and enhanced scheduling capabilities.
Full recap